Yes, which probably makes me less biased. I'm very qualified to understand the medicine. There's a reason Gavin Shepherd is backing this. They definitely have blockbuster potential and a wide range of applications in oncology. My concern is that from a purely financial point of view they look tenuous without an injection of capital or a capital raise. If they were financially more secure I'd join the party with no hesitation.
- Forums
- ASX - By Stock
- Ann: Appendix 4E and 2024 Annual Report
Yes, which probably makes me less biased. I'm very qualified to...
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $33.01M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 4.1¢ | $3.306K | 81.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 1355564 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 57450 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 1355564 | 0.040 |
3 | 243333 | 0.039 |
9 | 544473 | 0.038 |
2 | 109000 | 0.037 |
3 | 599000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 57450 | 2 |
0.042 | 148294 | 2 |
0.043 | 618217 | 3 |
0.044 | 120777 | 2 |
0.047 | 86129 | 3 |
Last trade - 15.45pm 05/11/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |